Authors

ESMO 2021 Updates in Gastric Cancer and Colorectal Cancer

Recognizing Appropriate Patients for an Antibody-Drug Conjugate: Case Studies in Bladder Cancer

Kay Macleod Named Associate Director for Basic Sciences for the Cancer Center

Dr. Garg on the Need for Novel Imaging Techniques in nmCRPC

Henry Ford Health + MSU Health Sciences Funds Five Cancer Research Grants to Advance Cancer Medicine, Combat Health Disparities

Dr. Strickler on the Results of Tucatinib Monotherapy in HER2+ CRC

Overall Survival After Surgery for Spinal Metastases Has Improved Over the Past Two Decades

Gymnastics Makes Me a Better Oncologist

Dr. Garber on the Efficacy of Adjuvant Olaparib in High-Risk, HER2-Negative Breast Cancer

Dr. Kindsfather on the Evolution of Reflex Testing in Lung Cancer

Dr Phillips on the Use of Bispecific Antibodies and CAR T-Cell Therapy in MCL and FL

Key Takeaways From Discussion

ACCC Welcomes Matt Devino, MPH, as Director, Cancer Care Delivery and Health Policy

Unmet Needs and Future Perspectives in the NSCLC Treatment Landscape

Role of a Pharmacist in Developing Treatment Pathways and Educating Patients

Dr Sun on Ongoing Research Efforts Examining Clonal Hematopoiesis in RCC

Multidisciplinary Management of Locoregional Non–Small Cell Lung Cancer

Smoking Cessation Support Plays a Vital Role in Improving Lung Cancer Screening

CAR T-Cell Therapy for Multiple Myeloma: Eliminating Disparities Through Accountability

Dr. Gulhati on Current Treatment Approaches in Pancreatic Cancer